Guided Therapeutics (OTCMKTS:GTHP) Announces Quarterly Earnings Results

Guided Therapeutics (OTCMKTS:GTHP) issued its earnings results on Thursday. The company reported ($0.01) EPS for the quarter, Zacks reports. The business had revenue of $0.06 million during the quarter.

Guided Therapeutics Price Performance

GTHP stock traded down $0.07 during trading on Friday, reaching $0.16. 6,681 shares of the company were exchanged, compared to its average volume of 13,189. Guided Therapeutics has a twelve month low of $0.06 and a twelve month high of $0.32. The company has a 50-day moving average of $0.25 and a two-hundred day moving average of $0.22. The company has a market capitalization of $13.38 million, a price-to-earnings ratio of -3.20 and a beta of 0.38.

Guided Therapeutics Company Profile

Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.